GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: BLU-222 | BLU222
Compound class:
Synthetic organic
Comment: BLU-222 is an oral cyclin-dependent kinase 2 (CDK2)-selective inhibitor from Blueprint Therapeutics. Its chemical structure was revealed during the first time disclosures session at the 2024 ACS spring meeting in New Orleans. BLU-222 is proposed to target solid tumours with CDK2/cyclin E1 amplifications that drive G1/S progression, such as certain ovarian cancers. The chemical structure of BLU-222 is identical to that for the INN cirtociclib (proposed list 132, Feb. 2025).
|
|
Bioactivity Comments |
BLU-222 IC50 vs. CDK2 is 2.6 nM (disclosed in a poster presented at AACR Annual meeting in 2022 [1]. |